Budd-Chiari syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


== Overview ==
== Overview ==
In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a rare disease. The incidence of Budd-Chiari syndrome was estimated to be  about 1 case per million population per year 100,000 individuals in Sweden. The annual case fatality rate of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is rare in children. Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8  to 1. Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.
In 2009-2013, the [[prevalence]] of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a [[Rare diseases|rare disease]]. The [[incidence]] of [[Budd-Chiari syndrome]] was estimated to be  about 1 case per million population per year 100,000 individuals in Sweden. The [[Case fatality rate|annual case fatality rate]] of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is [[rare]] in [[children]]. [[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8  to 1. Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
The Epidemiology and Demographics of Budd-Chiari syndrome are as follows:<ref name="pmid26558363">{{cite journal |vauthors=Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH |title=Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study |journal=Liver Int. |volume=36 |issue=7 |pages=1067–73 |year=2016 |pmid=26558363 |doi=10.1111/liv.13008 |url=}}</ref><ref name="pmid18694401">{{cite journal |vauthors=Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH |title=Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience |journal=Liver Int. |volume=29 |issue=2 |pages=253–9 |year=2009 |pmid=18694401 |doi=10.1111/j.1478-3231.2008.01838.x |url=}}</ref>
The [[Epidemiology]] and [[Demographics]] of Budd-Chiari syndrome are as follows:<ref name="pmid26558363">{{cite journal |vauthors=Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH |title=Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study |journal=Liver Int. |volume=36 |issue=7 |pages=1067–73 |year=2016 |pmid=26558363 |doi=10.1111/liv.13008 |url=}}</ref><ref name="pmid18694401">{{cite journal |vauthors=Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH |title=Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience |journal=Liver Int. |volume=29 |issue=2 |pages=253–9 |year=2009 |pmid=18694401 |doi=10.1111/j.1478-3231.2008.01838.x |url=}}</ref>
===Prevalence===
===Prevalence===
*In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea.
*In 2009-2013, the [[prevalence]] of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea.
===Incidence===
===Incidence===
*Budd-Chiari syndrome is a rare disease.
*Budd-Chiari syndrome is a [[rare disease]].
*The incidence of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden.  
*The [[incidence]] of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden.  
===Case Fatality Rate===
===Case Fatality Rate===
*The annual case fatality rate of Budd-Chiari syndrome is approximately 2.8%.  
*The annual [[case fatality rate]] of Budd-Chiari syndrome is approximately 2.8%.  
===Age===
===Age===
*Budd-Chiari syndrome commonly presents in the third or fourth decade of life.  
*Budd-Chiari syndrome commonly presents in the third or fourth decade of life.  
Line 20: Line 20:
*Budd-Chiari syndrome is rare in children.
*Budd-Chiari syndrome is rare in children.
===Gender===
===Gender===
*Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8  to 1.
*[[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8  to 1.
===Developed Countries===
===Developed Countries===
*Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.
*Budd-Chiari syndrome in the [[United States]] is predominantly seen in [[women]] and is commonly associated with hematologic disorders.
===Developing Countries===
===Developing Countries===
*Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.
*Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.

Revision as of 19:47, 13 November 2017

Budd-Chiari syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Budd-Chiari syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Budd-Chiari syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Budd-Chiari syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Budd-Chiari syndrome epidemiology and demographics

CDC on Budd-Chiari syndrome epidemiology and demographics

Budd-Chiari syndrome epidemiology and demographics in the news

Blogs on Budd-Chiari syndrome epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Budd-Chiari syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a rare disease. The incidence of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden. The annual case fatality rate of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is rare in children. Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8 to 1. Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.

Epidemiology and Demographics

The Epidemiology and Demographics of Budd-Chiari syndrome are as follows:[1][2]

Prevalence

  • In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea.

Incidence

  • Budd-Chiari syndrome is a rare disease.
  • The incidence of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden.

Case Fatality Rate

Age

  • Budd-Chiari syndrome commonly presents in the third or fourth decade of life.
  • The median age at diagnosis is 51 years.
  • Budd-Chiari syndrome is rare in children.

Gender

  • Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8 to 1.

Developed Countries

  • Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.

Developing Countries

  • Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.

References

  1. Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH (2016). "Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study". Liver Int. 36 (7): 1067–73. doi:10.1111/liv.13008. PMID 26558363.
  2. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH (2009). "Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience". Liver Int. 29 (2): 253–9. doi:10.1111/j.1478-3231.2008.01838.x. PMID 18694401.

Template:WS Template:WH